Pure Global
NCT05547841

Normal Reference Value for Echocardiography in Chinese Han Pregnancies

Normal Reference Value for Echocardiography in Chinese Han Pregnancies: a Prospective, Multicenter, Clinical Trial
First Hospital of China Medical University·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Pregnancy
Drug/Device/Intervention
Echocardiography acquisition
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
First Hospital of China Medical University
Location
Chongqing,Chongqing,Chongqing,Haikou,Jiamusi,Nanyang,Zhengzhou,Wuhan,Wuhan,Changchun,Jilin,Jilin,Siping,Yanji,Dalian,Dalian,Fushun,Jinzhou,Jinzhou,Shenyang,Shenyang,Shenyang,Shenyang,Tieling,Yinchuan,, China
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2022
End date
Aug 30, 2024
Enrollment
680 participants
Primary outcome

Measurement of echocardiographic parameters in Chinese Han pregnancies

Summary

The First Hospital of China Medical University initiated a multi-center study on the
 reference range of echocardiography in Chinese Han Pregnancies to determine the reference
 range of echocardiography in the pregnant population and to promote the clinical application
 of echocardiography in the pregnant population, thereby offering the value of early
 evaluation and early diagnosis for cardiac structure and function in the pregnant population.

ICD-10 classifications
Pregnancy confirmedPregnancy-related condition, unspecifiedAbdominal pregnancyPregnancy, not (yet) confirmedOvarian pregnancy
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05547841
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05547841 through Pure Global AI's free database. This phase not specified trial is sponsored by First Hospital of China Medical University and is currently Recruiting. The study focuses on Pregnancy. Target enrollment is 680 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.